Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer

Journal:

The New England Journal of Medicine

Published:

2025-12-11

DOI:

10.1056/nejmoa2514661

Affiliations:

35

Authors:

30

Go to article

Institutions	Authors	Share
Daiichi Sankyo US, United States of America (USA)	3.000000	0.10
Hospital São Lucas da PUCRS, Brazil	1.000000	0.03
Fujian Medical University Union Hospital, China	1.000000	0.03
Daiichi Sankyo France SAS, France	1.000000	0.03
Taoyuan Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taiwan	1.000000	0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	1.000000	0.03
Sun Yat-sen Memorial Hospital, SYSU, China	1.000000	0.03
Fourth Hospital of Hebei Medical University, China	1.000000	0.03
National University Cancer Institute (NCIS), Singapore	1.000000	0.03
Instituto Peruano de Oncología y Radioterapia (IPOR), Peru	1.000000	0.03
Harbin Medical University Cancer Hospital, China	1.000000	0.03
Cleveland Clinic, United States of America (USA)	1.000000	0.03
Samsung Medical Center (SMC), South Korea	1.000000	0.03
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.03
Barretos Cancer Hospital, Brazil	1.000000	0.03
Asan Medical Center (AMC), South Korea	1.000000	0.03
Shandong Cancer Hospital, China	1.000000	0.03
Hospital Civil de Guadalajara, Mexico	1.000000	0.03
Tokai University, Japan	1.000000	0.03
Fudan University Shanghai Cancer Center (FUSCC), China	1.000000	0.03
MacKay Memorial Hospital (MMH), Taiwan	1.000000	0.03
Seoul National University Hospital (SNUH), South Korea	1.000000	0.03
Maria Sklodowska-Curie National Research Institute of Oncology, Poland	1.000000	0.03
The First Hospital of Jilin University, China	1.000000	0.03
Hospital Clinic of Barcelona, Spain	0.500000	0.02
German Breast Group GmbH (GBG), Germany	0.500000	0.02
HMU Health and Medical University (HMU), Germany	0.500000	0.02
Helios Clinic Berlin-Buch, Germany	0.500000	0.02
Goethe University Frankfurt (GU), Germany	0.500000	0.02
University of Barcelona (UB), Spain	0.500000	0.02
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	0.333333	0.01
University of Pittsburgh (Pitt), United States of America (USA)	0.333333	0.01
National Surgical Adjuvant Breast and Bowel Project (NSABP), United States of America (USA)	0.333333	0.01

Interested in Oncology and Carcinogenesis?